nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—OPRD1—epilepsy syndrome	0.0883	0.374	CbGaD
Methadone—OPRM1—epilepsy syndrome	0.0676	0.286	CbGaD
Methadone—CYP2C19—epilepsy syndrome	0.0353	0.149	CbGaD
Methadone—GRIN3A—Felbamate—epilepsy syndrome	0.0326	0.0959	CbGbCtD
Methadone—Phenylbutazone—Fosphenytoin—epilepsy syndrome	0.0263	0.1	CrCrCtD
Methadone—CYP2D6—epilepsy syndrome	0.0262	0.111	CbGaD
Methadone—Oxaprozin—Phenytoin—epilepsy syndrome	0.0188	0.0719	CrCrCtD
Methadone—ABCB1—epilepsy syndrome	0.0187	0.0791	CbGaD
Methadone—Phenylbutazone—Phenytoin—epilepsy syndrome	0.018	0.0689	CrCrCtD
Methadone—Oxaprozin—Carbamazepine—epilepsy syndrome	0.0174	0.0664	CrCrCtD
Methadone—CYP2C18—Clobazam—epilepsy syndrome	0.0161	0.0475	CbGbCtD
Methadone—Modafinil—Fosphenytoin—epilepsy syndrome	0.0161	0.0616	CrCrCtD
Methadone—Antazoline—Phenytoin—epilepsy syndrome	0.015	0.0571	CrCrCtD
Methadone—Phenylbutazone—Clobazam—epilepsy syndrome	0.0147	0.0562	CrCrCtD
Methadone—CYP2C18—Phenytoin—epilepsy syndrome	0.012	0.0353	CbGbCtD
Methadone—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0112	0.0429	CrCrCtD
Methadone—CYP2C18—Propofol—epilepsy syndrome	0.0112	0.0329	CbGbCtD
Methadone—Modafinil—Phenytoin—epilepsy syndrome	0.0111	0.0423	CrCrCtD
Methadone—CYP2C18—Phenobarbital—epilepsy syndrome	0.0107	0.0314	CbGbCtD
Methadone—Ethopropazine—Carbamazepine—epilepsy syndrome	0.0104	0.0399	CrCrCtD
Methadone—Trimipramine—Carbamazepine—epilepsy syndrome	0.0102	0.039	CrCrCtD
Methadone—Modafinil—Carbamazepine—epilepsy syndrome	0.0102	0.039	CrCrCtD
Methadone—CYP2C18—Diazepam—epilepsy syndrome	0.0101	0.0298	CbGbCtD
Methadone—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.0094	0.0359	CrCrCtD
Methadone—Modafinil—Oxcarbazepine—epilepsy syndrome	0.0094	0.0359	CrCrCtD
Methadone—Promethazine—Carbamazepine—epilepsy syndrome	0.00865	0.0331	CrCrCtD
Methadone—Alimemazine—Carbamazepine—epilepsy syndrome	0.0085	0.0325	CrCrCtD
Methadone—Benzphetamine—Phenytoin—epilepsy syndrome	0.00831	0.0318	CrCrCtD
Methadone—CYP2C18—Valproic Acid—epilepsy syndrome	0.00799	0.0235	CbGbCtD
Methadone—Promethazine—Oxcarbazepine—epilepsy syndrome	0.00797	0.0305	CrCrCtD
Methadone—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.00783	0.0299	CrCrCtD
Methadone—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.0077	0.0294	CrCrCtD
Methadone—Diphenhydramine—Phenytoin—epilepsy syndrome	0.00738	0.0282	CrCrCtD
Methadone—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.00711	0.0272	CrCrCtD
Methadone—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00589	0.0173	CbGbCtD
Methadone—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00531	0.0156	CbGbCtD
Methadone—CYP2B6—Clobazam—epilepsy syndrome	0.00511	0.015	CbGbCtD
Methadone—CYP2C8—Trimethadione—epilepsy syndrome	0.00474	0.014	CbGbCtD
Methadone—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00446	0.0131	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00444	0.0131	CbGbCtD
Methadone—CYP3A7—Carbamazepine—epilepsy syndrome	0.00444	0.0131	CbGbCtD
Methadone—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00428	0.0126	CbGbCtD
Methadone—CYP2B6—Carbamazepine—epilepsy syndrome	0.00423	0.0124	CbGbCtD
Methadone—CYP3A7—Phenytoin—epilepsy syndrome	0.00399	0.0117	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00399	0.0117	CbGbCtD
Methadone—CYP2C19—Felbamate—epilepsy syndrome	0.00398	0.0117	CbGbCtD
Methadone—CYP2C19—Trimethadione—epilepsy syndrome	0.00398	0.0117	CbGbCtD
Methadone—CYP2B6—Primidone—epilepsy syndrome	0.00395	0.0116	CbGbCtD
Methadone—CYP2B6—Phenytoin—epilepsy syndrome	0.0038	0.0112	CbGbCtD
Methadone—ABCB1—Levetiracetam—epilepsy syndrome	0.00378	0.0111	CbGbCtD
Methadone—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00374	0.011	CbGbCtD
Methadone—CYP3A7—Phenobarbital—epilepsy syndrome	0.00355	0.0104	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00355	0.0104	CbGbCtD
Methadone—CYP2B6—Propofol—epilepsy syndrome	0.00354	0.0104	CbGbCtD
Methadone—CYP3A7—Midazolam—epilepsy syndrome	0.0035	0.0103	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0035	0.0103	CbGbCtD
Methadone—CYP2B6—Phenobarbital—epilepsy syndrome	0.00338	0.00995	CbGbCtD
Methadone—CYP3A7—Diazepam—epilepsy syndrome	0.00337	0.0099	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00337	0.0099	CbGbCtD
Methadone—CYP2B6—Midazolam—epilepsy syndrome	0.00334	0.00981	CbGbCtD
Methadone—CYP3A5—Carbamazepine—epilepsy syndrome	0.00333	0.0098	CbGbCtD
Methadone—CYP2C9—Trimethadione—epilepsy syndrome	0.00331	0.00973	CbGbCtD
Methadone—CYP2C19—Clobazam—epilepsy syndrome	0.00324	0.00954	CbGbCtD
Methadone—CYP2B6—Diazepam—epilepsy syndrome	0.00321	0.00943	CbGbCtD
Methadone—CYP2C8—Carbamazepine—epilepsy syndrome	0.0032	0.00942	CbGbCtD
Methadone—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00311	0.00915	CbGbCtD
Methadone—CYP2C8—Primidone—epilepsy syndrome	0.00299	0.0088	CbGbCtD
Methadone—CYP3A5—Phenytoin—epilepsy syndrome	0.00299	0.00879	CbGbCtD
Methadone—CYP2C8—Phenytoin—epilepsy syndrome	0.00287	0.00845	CbGbCtD
Methadone—CYP2C19—Carbamazepine—epilepsy syndrome	0.00269	0.00791	CbGbCtD
Methadone—CYP2C8—Propofol—epilepsy syndrome	0.00268	0.00788	CbGbCtD
Methadone—CYP3A5—Phenobarbital—epilepsy syndrome	0.00266	0.00783	CbGbCtD
Methadone—CYP3A5—Midazolam—epilepsy syndrome	0.00263	0.00773	CbGbCtD
Methadone—ABCB1—Clobazam—epilepsy syndrome	0.00262	0.0077	CbGbCtD
Methadone—CHRNA10—ear—epilepsy syndrome	0.00261	0.13	CbGeAlD
Methadone—CYP2C8—Phenobarbital—epilepsy syndrome	0.00256	0.00753	CbGbCtD
Methadone—CYP2B6—Valproic Acid—epilepsy syndrome	0.00253	0.00743	CbGbCtD
Methadone—CYP3A5—Diazepam—epilepsy syndrome	0.00253	0.00743	CbGbCtD
Methadone—ABCB1—Lamotrigine—epilepsy syndrome	0.00252	0.00741	CbGbCtD
Methadone—CYP2C19—Primidone—epilepsy syndrome	0.00251	0.00738	CbGbCtD
Methadone—CYP1A2—Carbamazepine—epilepsy syndrome	0.00248	0.00729	CbGbCtD
Methadone—CYP2C8—Diazepam—epilepsy syndrome	0.00243	0.00714	CbGbCtD
Methadone—CYP2C19—Phenytoin—epilepsy syndrome	0.00241	0.00709	CbGbCtD
Methadone—CYP1A2—Primidone—epilepsy syndrome	0.00232	0.00681	CbGbCtD
Methadone—CYP2C19—Propofol—epilepsy syndrome	0.00225	0.00661	CbGbCtD
Methadone—CYP2C9—Carbamazepine—epilepsy syndrome	0.00224	0.00657	CbGbCtD
Methadone—ABCB1—Carbamazepine—epilepsy syndrome	0.00217	0.00638	CbGbCtD
Methadone—CYP2C19—Phenobarbital—epilepsy syndrome	0.00215	0.00632	CbGbCtD
Methadone—CYP2C9—Primidone—epilepsy syndrome	0.00209	0.00614	CbGbCtD
Methadone—CYP1A2—Propofol—epilepsy syndrome	0.00208	0.0061	CbGbCtD
Methadone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00207	0.00609	CbGbCtD
Methadone—CYP2C19—Diazepam—epilepsy syndrome	0.00204	0.00599	CbGbCtD
Methadone—CYP2C9—Phenytoin—epilepsy syndrome	0.002	0.0059	CbGbCtD
Methadone—CYP3A5—Valproic Acid—epilepsy syndrome	0.00199	0.00586	CbGbCtD
Methadone—CYP2C19—Zonisamide—epilepsy syndrome	0.00199	0.00585	CbGbCtD
Methadone—CYP1A2—Phenobarbital—epilepsy syndrome	0.00198	0.00583	CbGbCtD
Methadone—HTR3A—vagus nerve—epilepsy syndrome	0.00195	0.0971	CbGeAlD
Methadone—ABCB1—Phenytoin—epilepsy syndrome	0.00195	0.00572	CbGbCtD
Methadone—CYP3A4—Felbamate—epilepsy syndrome	0.00192	0.00566	CbGbCtD
Methadone—CYP3A4—Trimethadione—epilepsy syndrome	0.00192	0.00566	CbGbCtD
Methadone—CYP2C8—Valproic Acid—epilepsy syndrome	0.00191	0.00563	CbGbCtD
Methadone—CYP1A2—Diazepam—epilepsy syndrome	0.00188	0.00553	CbGbCtD
Methadone—CYP2C9—Propofol—epilepsy syndrome	0.00187	0.0055	CbGbCtD
Methadone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00181	0.00532	CbGbCtD
Methadone—CYP2C9—Phenobarbital—epilepsy syndrome	0.00179	0.00525	CbGbCtD
Methadone—ABCB1—Phenobarbital—epilepsy syndrome	0.00173	0.0051	CbGbCtD
Methadone—ABCB1—Midazolam—epilepsy syndrome	0.00171	0.00503	CbGbCtD
Methadone—CYP2D6—Propofol—epilepsy syndrome	0.00171	0.00503	CbGbCtD
Methadone—CYP2C9—Diazepam—epilepsy syndrome	0.00169	0.00498	CbGbCtD
Methadone—ABCB1—Diazepam—epilepsy syndrome	0.00164	0.00483	CbGbCtD
Methadone—CYP3A4—Clonazepam—epilepsy syndrome	0.00164	0.00481	CbGbCtD
Methadone—CYP2C19—Valproic Acid—epilepsy syndrome	0.00161	0.00472	CbGbCtD
Methadone—CYP3A4—Clobazam—epilepsy syndrome	0.00157	0.00461	CbGbCtD
Methadone—CYP1A2—Valproic Acid—epilepsy syndrome	0.00148	0.00436	CbGbCtD
Methadone—CYP2C19—Topiramate—epilepsy syndrome	0.00145	0.00426	CbGbCtD
Methadone—CYP2C9—Valproic Acid—epilepsy syndrome	0.00134	0.00393	CbGbCtD
Methadone—CYP3A4—Rufinamide—epilepsy syndrome	0.00133	0.00392	CbGbCtD
Methadone—CYP3A4—Carbamazepine—epilepsy syndrome	0.0013	0.00382	CbGbCtD
Methadone—CYP3A4—Primidone—epilepsy syndrome	0.00121	0.00357	CbGbCtD
Methadone—CYP3A4—Phenytoin—epilepsy syndrome	0.00117	0.00343	CbGbCtD
Methadone—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00111	0.0551	CbGeAlD
Methadone—CYP3A4—Propofol—epilepsy syndrome	0.00109	0.0032	CbGbCtD
Methadone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00104	0.00306	CbGbCtD
Methadone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00104	0.00306	CbGbCtD
Methadone—CYP3A4—Midazolam—epilepsy syndrome	0.00102	0.00301	CbGbCtD
Methadone—OPRD1—ganglion—epilepsy syndrome	0.00101	0.0503	CbGeAlD
Methadone—CYP3A4—Diazepam—epilepsy syndrome	0.000985	0.0029	CbGbCtD
Methadone—CYP3A4—Zonisamide—epilepsy syndrome	0.000961	0.00283	CbGbCtD
Methadone—CYP3A4—Valproic Acid—epilepsy syndrome	0.000776	0.00228	CbGbCtD
Methadone—HTR3A—ganglion—epilepsy syndrome	0.000752	0.0374	CbGeAlD
Methadone—CYP3A4—Topiramate—epilepsy syndrome	0.000701	0.00206	CbGbCtD
Methadone—OPRM1—ganglion—epilepsy syndrome	0.000689	0.0343	CbGeAlD
Methadone—GRIN3A—forebrain—epilepsy syndrome	0.000602	0.03	CbGeAlD
Methadone—GRIN3A—telencephalon—epilepsy syndrome	0.000553	0.0275	CbGeAlD
Methadone—OPRD1—forebrain—epilepsy syndrome	0.000424	0.0211	CbGeAlD
Methadone—OPRK1—forebrain—epilepsy syndrome	0.000406	0.0202	CbGeAlD
Methadone—CHRNA10—head—epilepsy syndrome	0.00039	0.0194	CbGeAlD
Methadone—OPRD1—telencephalon—epilepsy syndrome	0.00039	0.0194	CbGeAlD
Methadone—GRIN3A—head—epilepsy syndrome	0.000345	0.0172	CbGeAlD
Methadone—HTR3A—brainstem—epilepsy syndrome	0.000327	0.0163	CbGeAlD
Methadone—GRIN3A—nervous system—epilepsy syndrome	0.000327	0.0163	CbGeAlD
Methadone—HTR3A—forebrain—epilepsy syndrome	0.000315	0.0157	CbGeAlD
Methadone—GRIN3A—central nervous system—epilepsy syndrome	0.000314	0.0157	CbGeAlD
Methadone—OPRM1—brainstem—epilepsy syndrome	0.0003	0.0149	CbGeAlD
Methadone—HTR3A—telencephalon—epilepsy syndrome	0.00029	0.0144	CbGeAlD
Methadone—OPRM1—forebrain—epilepsy syndrome	0.000289	0.0144	CbGeAlD
Methadone—OPRM1—telencephalon—epilepsy syndrome	0.000266	0.0132	CbGeAlD
Methadone—Isoaminile—CA4—epilepsy syndrome	0.000262	0.0881	CrCbGaD
Methadone—GRIN3A—brain—epilepsy syndrome	0.00025	0.0124	CbGeAlD
Methadone—CYP19A1—forebrain—epilepsy syndrome	0.000243	0.0121	CbGeAlD
Methadone—OPRD1—head—epilepsy syndrome	0.000243	0.0121	CbGeAlD
Methadone—OPRK1—head—epilepsy syndrome	0.000233	0.0116	CbGeAlD
Methadone—OPRD1—nervous system—epilepsy syndrome	0.00023	0.0115	CbGeAlD
Methadone—OPRD1—central nervous system—epilepsy syndrome	0.000222	0.011	CbGeAlD
Methadone—OPRK1—nervous system—epilepsy syndrome	0.000221	0.011	CbGeAlD
Methadone—OPRK1—central nervous system—epilepsy syndrome	0.000212	0.0106	CbGeAlD
Methadone—CYP2D6—hindbrain—epilepsy syndrome	0.00021	0.0104	CbGeAlD
Methadone—OPRK1—cerebellum—epilepsy syndrome	0.000208	0.0103	CbGeAlD
Methadone—OPRM1—midbrain—epilepsy syndrome	0.000191	0.0095	CbGeAlD
Methadone—OPRM1—spinal cord—epilepsy syndrome	0.000186	0.00927	CbGeAlD
Methadone—HTR3A—head—epilepsy syndrome	0.000181	0.00899	CbGeAlD
Methadone—OPRD1—brain—epilepsy syndrome	0.000176	0.00876	CbGeAlD
Methadone—HTR3A—nervous system—epilepsy syndrome	0.000171	0.00852	CbGeAlD
Methadone—OPRK1—brain—epilepsy syndrome	0.000169	0.0084	CbGeAlD
Methadone—OPRM1—head—epilepsy syndrome	0.000166	0.00824	CbGeAlD
Methadone—HTR3A—central nervous system—epilepsy syndrome	0.000165	0.0082	CbGeAlD
Methadone—OPRM1—nervous system—epilepsy syndrome	0.000157	0.00781	CbGeAlD
Methadone—Disopyramide—KCND2—epilepsy syndrome	0.000155	0.0522	CrCbGaD
Methadone—OPRM1—central nervous system—epilepsy syndrome	0.000151	0.00752	CbGeAlD
Methadone—CYP19A1—head—epilepsy syndrome	0.000139	0.00692	CbGeAlD
Methadone—CYP19A1—nervous system—epilepsy syndrome	0.000132	0.00656	CbGeAlD
Methadone—HTR3A—brain—epilepsy syndrome	0.000131	0.00651	CbGeAlD
Methadone—CYP19A1—central nervous system—epilepsy syndrome	0.000127	0.00632	CbGeAlD
Methadone—CYP2D6—brainstem—epilepsy syndrome	0.00012	0.00598	CbGeAlD
Methadone—OPRM1—brain—epilepsy syndrome	0.00012	0.00597	CbGeAlD
Methadone—CYP2D6—forebrain—epilepsy syndrome	0.000116	0.00577	CbGeAlD
Methadone—CYP2D6—telencephalon—epilepsy syndrome	0.000107	0.00531	CbGeAlD
Methadone—CYP19A1—brain—epilepsy syndrome	0.000101	0.00502	CbGeAlD
Methadone—CYP2B6—head—epilepsy syndrome	8.93e-05	0.00445	CbGeAlD
Methadone—Difenoxin—OPRM1—epilepsy syndrome	8.83e-05	0.0297	CrCbGaD
Methadone—Loperamide—CACNA1A—epilepsy syndrome	8.64e-05	0.029	CrCbGaD
Methadone—CYP2B6—nervous system—epilepsy syndrome	8.47e-05	0.00422	CbGeAlD
Methadone—ABCB1—forebrain—epilepsy syndrome	8.34e-05	0.00415	CbGeAlD
Methadone—CYP2B6—central nervous system—epilepsy syndrome	8.15e-05	0.00406	CbGeAlD
Methadone—Diphenoxylate—OPRD1—epilepsy syndrome	8.13e-05	0.0273	CrCbGaD
Methadone—ABCB1—telencephalon—epilepsy syndrome	7.67e-05	0.00382	CbGeAlD
Methadone—CYP2C8—brain—epilepsy syndrome	7.22e-05	0.00359	CbGeAlD
Methadone—Methadyl Acetate—OPRM1—epilepsy syndrome	7.2e-05	0.0242	CrCbGaD
Methadone—CYP2D6—head—epilepsy syndrome	6.64e-05	0.0033	CbGeAlD
Methadone—Clidinium—CHRM3—epilepsy syndrome	6.63e-05	0.0223	CrCbGaD
Methadone—CYP2B6—brain—epilepsy syndrome	6.47e-05	0.00322	CbGeAlD
Methadone—CYP3A4—nervous system—epilepsy syndrome	6.39e-05	0.00318	CbGeAlD
Methadone—Trospium—CHRM3—epilepsy syndrome	6.38e-05	0.0214	CrCbGaD
Methadone—Fexofenadine—SLCO1A2—epilepsy syndrome	6.37e-05	0.0214	CrCbGaD
Methadone—CYP2D6—nervous system—epilepsy syndrome	6.29e-05	0.00313	CbGeAlD
Methadone—Diphenoxylate—OPRM1—epilepsy syndrome	6.22e-05	0.0209	CrCbGaD
Methadone—Clidinium—CHRM1—epilepsy syndrome	6.18e-05	0.0208	CrCbGaD
Methadone—CYP3A4—central nervous system—epilepsy syndrome	6.16e-05	0.00306	CbGeAlD
Methadone—CYP2D6—central nervous system—epilepsy syndrome	6.06e-05	0.00302	CbGeAlD
Methadone—ABCB1—medulla oblongata—epilepsy syndrome	6.02e-05	0.003	CbGeAlD
Methadone—Loperamide—POMC—epilepsy syndrome	5.99e-05	0.0201	CrCbGaD
Methadone—Trospium—CHRM1—epilepsy syndrome	5.95e-05	0.02	CrCbGaD
Methadone—CYP2D6—cerebellum—epilepsy syndrome	5.92e-05	0.00295	CbGeAlD
Methadone—Isopropamide—CHRM3—epilepsy syndrome	5.63e-05	0.0189	CrCbGaD
Methadone—ABCB1—midbrain—epilepsy syndrome	5.51e-05	0.00274	CbGeAlD
Methadone—ABCB1—spinal cord—epilepsy syndrome	5.37e-05	0.00267	CbGeAlD
Methadone—Mepenzolate—CHRM3—epilepsy syndrome	5.33e-05	0.0179	CrCbGaD
Methadone—Isopropamide—CHRM1—epilepsy syndrome	5.26e-05	0.0177	CrCbGaD
Methadone—Doxylamine—CHRM1—epilepsy syndrome	5.26e-05	0.0177	CrCbGaD
Methadone—Mepenzolate—CHRM1—epilepsy syndrome	4.97e-05	0.0167	CrCbGaD
Methadone—Trospium—CHRM2—epilepsy syndrome	4.86e-05	0.0163	CrCbGaD
Methadone—CYP2D6—brain—epilepsy syndrome	4.81e-05	0.00239	CbGeAlD
Methadone—ABCB1—head—epilepsy syndrome	4.77e-05	0.00238	CbGeAlD
Methadone—Diphenidol—CHRM3—epilepsy syndrome	4.67e-05	0.0157	CrCbGaD
Methadone—Darifenacin—CHRM3—epilepsy syndrome	4.63e-05	0.0156	CrCbGaD
Methadone—ABCB1—nervous system—epilepsy syndrome	4.53e-05	0.00225	CbGeAlD
Methadone—Orphenadrine—SCN9A—epilepsy syndrome	4.46e-05	0.015	CrCbGaD
Methadone—ABCB1—central nervous system—epilepsy syndrome	4.36e-05	0.00217	CbGeAlD
Methadone—Diphenidol—CHRM1—epilepsy syndrome	4.35e-05	0.0146	CrCbGaD
Methadone—Darifenacin—CHRM1—epilepsy syndrome	4.32e-05	0.0145	CrCbGaD
Methadone—Clotrimazole—CYP11A1—epilepsy syndrome	4.28e-05	0.0144	CrCbGaD
Methadone—Disopyramide—CHRM3—epilepsy syndrome	4.27e-05	0.0144	CrCbGaD
Methadone—ABCB1—cerebellum—epilepsy syndrome	4.26e-05	0.00212	CbGeAlD
Methadone—Orphenadrine—SCN4A—epilepsy syndrome	4.09e-05	0.0138	CrCbGaD
Methadone—Mepenzolate—CHRM2—epilepsy syndrome	4.06e-05	0.0136	CrCbGaD
Methadone—Disopyramide—CHRM1—epilepsy syndrome	3.98e-05	0.0134	CrCbGaD
Methadone—Ethopropazine—CHRM1—epilepsy syndrome	3.79e-05	0.0127	CrCbGaD
Methadone—Diphenidol—CHRM2—epilepsy syndrome	3.56e-05	0.012	CrCbGaD
Methadone—Urticaria—Carbamazepine—epilepsy syndrome	3.54e-05	0.000374	CcSEcCtD
Methadone—Dextropropoxyphene—OPRD1—epilepsy syndrome	3.54e-05	0.0119	CrCbGaD
Methadone—Vomiting—Levetiracetam—epilepsy syndrome	3.53e-05	0.000374	CcSEcCtD
Methadone—Darifenacin—CHRM2—epilepsy syndrome	3.53e-05	0.0119	CrCbGaD
Methadone—Headache—Midazolam—epilepsy syndrome	3.53e-05	0.000373	CcSEcCtD
Methadone—Pruritus—Felbamate—epilepsy syndrome	3.52e-05	0.000373	CcSEcCtD
Methadone—Body temperature increased—Carbamazepine—epilepsy syndrome	3.52e-05	0.000372	CcSEcCtD
Methadone—Abdominal pain—Carbamazepine—epilepsy syndrome	3.52e-05	0.000372	CcSEcCtD
Methadone—Diarrhoea—Diazepam—epilepsy syndrome	3.52e-05	0.000372	CcSEcCtD
Methadone—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	3.52e-05	0.000372	CcSEcCtD
Methadone—Rash—Levetiracetam—epilepsy syndrome	3.5e-05	0.000371	CcSEcCtD
Methadone—Dermatitis—Levetiracetam—epilepsy syndrome	3.5e-05	0.00037	CcSEcCtD
Methadone—Fentanyl—OPRD1—epilepsy syndrome	3.5e-05	0.0118	CrCbGaD
Methadone—Asthenia—Zonisamide—epilepsy syndrome	3.5e-05	0.00037	CcSEcCtD
Methadone—Dry mouth—Valproic Acid—epilepsy syndrome	3.49e-05	0.000369	CcSEcCtD
Methadone—Agitation—Pregabalin—epilepsy syndrome	3.48e-05	0.000368	CcSEcCtD
Methadone—Headache—Levetiracetam—epilepsy syndrome	3.48e-05	0.000368	CcSEcCtD
Methadone—Erythema—Gabapentin—epilepsy syndrome	3.48e-05	0.000368	CcSEcCtD
Methadone—Hypersensitivity—Clonazepam—epilepsy syndrome	3.46e-05	0.000366	CcSEcCtD
Methadone—ABCB1—brain—epilepsy syndrome	3.46e-05	0.00172	CbGeAlD
Methadone—Dizziness—Vigabatrin—epilepsy syndrome	3.46e-05	0.000366	CcSEcCtD
Methadone—Confusional state—Valproic Acid—epilepsy syndrome	3.45e-05	0.000365	CcSEcCtD
Methadone—Pruritus—Zonisamide—epilepsy syndrome	3.45e-05	0.000365	CcSEcCtD
Methadone—Hypersensitivity—Phenytoin—epilepsy syndrome	3.44e-05	0.000364	CcSEcCtD
Methadone—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.42e-05	0.000362	CcSEcCtD
Methadone—Oedema—Valproic Acid—epilepsy syndrome	3.42e-05	0.000362	CcSEcCtD
Methadone—Urticaria—Lamotrigine—epilepsy syndrome	3.42e-05	0.000362	CcSEcCtD
Methadone—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.42e-05	0.000362	CcSEcCtD
Methadone—Bradycardia—Topiramate—epilepsy syndrome	3.42e-05	0.000362	CcSEcCtD
Methadone—Nausea—Propofol—epilepsy syndrome	3.42e-05	0.000361	CcSEcCtD
Methadone—Vomiting—Fosphenytoin—epilepsy syndrome	3.41e-05	0.000361	CcSEcCtD
Methadone—Diarrhoea—Felbamate—epilepsy syndrome	3.41e-05	0.00036	CcSEcCtD
Methadone—Vertigo—Pregabalin—epilepsy syndrome	3.41e-05	0.00036	CcSEcCtD
Methadone—Abdominal pain—Lamotrigine—epilepsy syndrome	3.4e-05	0.00036	CcSEcCtD
Methadone—Body temperature increased—Lamotrigine—epilepsy syndrome	3.4e-05	0.00036	CcSEcCtD
Methadone—Dizziness—Diazepam—epilepsy syndrome	3.4e-05	0.00036	CcSEcCtD
Methadone—Syncope—Pregabalin—epilepsy syndrome	3.4e-05	0.000359	CcSEcCtD
Methadone—Rash—Fosphenytoin—epilepsy syndrome	3.38e-05	0.000358	CcSEcCtD
Methadone—Dermatitis—Fosphenytoin—epilepsy syndrome	3.38e-05	0.000357	CcSEcCtD
Methadone—Asthenia—Clonazepam—epilepsy syndrome	3.37e-05	0.000357	CcSEcCtD
Methadone—Loperamide—OPRD1—epilepsy syndrome	3.37e-05	0.0113	CrCbGaD
Methadone—Headache—Fosphenytoin—epilepsy syndrome	3.36e-05	0.000355	CcSEcCtD
Methadone—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.35e-05	0.000354	CcSEcCtD
Methadone—Palpitations—Pregabalin—epilepsy syndrome	3.35e-05	0.000354	CcSEcCtD
Methadone—Asthenia—Phenytoin—epilepsy syndrome	3.35e-05	0.000354	CcSEcCtD
Methadone—Nausea—Midazolam—epilepsy syndrome	3.34e-05	0.000353	CcSEcCtD
Methadone—Hallucination—Topiramate—epilepsy syndrome	3.34e-05	0.000353	CcSEcCtD
Methadone—Muscle spasms—Gabapentin—epilepsy syndrome	3.34e-05	0.000353	CcSEcCtD
Methadone—Tachycardia—Valproic Acid—epilepsy syndrome	3.34e-05	0.000353	CcSEcCtD
Methadone—Diarrhoea—Zonisamide—epilepsy syndrome	3.34e-05	0.000353	CcSEcCtD
Methadone—Loss of consciousness—Pregabalin—epilepsy syndrome	3.33e-05	0.000352	CcSEcCtD
Methadone—Asthenia—Oxcarbazepine—epilepsy syndrome	3.33e-05	0.000352	CcSEcCtD
Methadone—Pruritus—Clonazepam—epilepsy syndrome	3.32e-05	0.000352	CcSEcCtD
Methadone—Vomiting—Vigabatrin—epilepsy syndrome	3.32e-05	0.000351	CcSEcCtD
Methadone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.31e-05	0.00035	CcSEcCtD
Methadone—Pruritus—Phenytoin—epilepsy syndrome	3.3e-05	0.000349	CcSEcCtD
Methadone—Nausea—Levetiracetam—epilepsy syndrome	3.3e-05	0.000349	CcSEcCtD
Methadone—Rash—Vigabatrin—epilepsy syndrome	3.3e-05	0.000349	CcSEcCtD
Methadone—Dizziness—Felbamate—epilepsy syndrome	3.29e-05	0.000348	CcSEcCtD
Methadone—Dermatitis—Vigabatrin—epilepsy syndrome	3.29e-05	0.000348	CcSEcCtD
Methadone—Pruritus—Oxcarbazepine—epilepsy syndrome	3.29e-05	0.000347	CcSEcCtD
Methadone—Convulsion—Pregabalin—epilepsy syndrome	3.28e-05	0.000347	CcSEcCtD
Methadone—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.28e-05	0.000347	CcSEcCtD
Methadone—Headache—Vigabatrin—epilepsy syndrome	3.28e-05	0.000346	CcSEcCtD
Methadone—Vomiting—Diazepam—epilepsy syndrome	3.27e-05	0.000346	CcSEcCtD
Methadone—Anorexia—Valproic Acid—epilepsy syndrome	3.26e-05	0.000345	CcSEcCtD
Methadone—Tremor—Gabapentin—epilepsy syndrome	3.26e-05	0.000344	CcSEcCtD
Methadone—Disopyramide—CHRM2—epilepsy syndrome	3.25e-05	0.0109	CrCbGaD
Methadone—Rash—Diazepam—epilepsy syndrome	3.25e-05	0.000343	CcSEcCtD
Methadone—Dermatitis—Diazepam—epilepsy syndrome	3.24e-05	0.000343	CcSEcCtD
Methadone—Visual impairment—Topiramate—epilepsy syndrome	3.24e-05	0.000342	CcSEcCtD
Methadone—Dizziness—Zonisamide—epilepsy syndrome	3.22e-05	0.000341	CcSEcCtD
Methadone—Headache—Diazepam—epilepsy syndrome	3.22e-05	0.000341	CcSEcCtD
Methadone—Anxiety—Pregabalin—epilepsy syndrome	3.22e-05	0.00034	CcSEcCtD
Methadone—Diarrhoea—Clonazepam—epilepsy syndrome	3.22e-05	0.00034	CcSEcCtD
Methadone—Hypotension—Valproic Acid—epilepsy syndrome	3.2e-05	0.000338	CcSEcCtD
Methadone—Asthenia—Carbamazepine—epilepsy syndrome	3.2e-05	0.000338	CcSEcCtD
Methadone—Agitation—Gabapentin—epilepsy syndrome	3.19e-05	0.000338	CcSEcCtD
Methadone—Diarrhoea—Phenytoin—epilepsy syndrome	3.19e-05	0.000338	CcSEcCtD
Methadone—Nausea—Fosphenytoin—epilepsy syndrome	3.19e-05	0.000337	CcSEcCtD
Methadone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.18e-05	0.000336	CcSEcCtD
Methadone—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.17e-05	0.000335	CcSEcCtD
Methadone—Vomiting—Felbamate—epilepsy syndrome	3.17e-05	0.000335	CcSEcCtD
Methadone—Dry mouth—Pregabalin—epilepsy syndrome	3.16e-05	0.000334	CcSEcCtD
Methadone—Pruritus—Carbamazepine—epilepsy syndrome	3.15e-05	0.000333	CcSEcCtD
Methadone—Rash—Felbamate—epilepsy syndrome	3.14e-05	0.000332	CcSEcCtD
Methadone—Dermatitis—Felbamate—epilepsy syndrome	3.14e-05	0.000332	CcSEcCtD
Methadone—Levomethadyl Acetate—OPRM1—epilepsy syndrome	3.13e-05	0.0105	CrCbGaD
Methadone—Vertigo—Gabapentin—epilepsy syndrome	3.12e-05	0.00033	CcSEcCtD
Methadone—Headache—Felbamate—epilepsy syndrome	3.12e-05	0.00033	CcSEcCtD
Methadone—Confusional state—Pregabalin—epilepsy syndrome	3.12e-05	0.00033	CcSEcCtD
Methadone—Flushing—Topiramate—epilepsy syndrome	3.12e-05	0.00033	CcSEcCtD
Methadone—Syncope—Gabapentin—epilepsy syndrome	3.12e-05	0.00033	CcSEcCtD
Methadone—Dizziness—Clonazepam—epilepsy syndrome	3.11e-05	0.000329	CcSEcCtD
Methadone—Nausea—Vigabatrin—epilepsy syndrome	3.11e-05	0.000328	CcSEcCtD
Methadone—Vomiting—Zonisamide—epilepsy syndrome	3.1e-05	0.000328	CcSEcCtD
Methadone—Insomnia—Valproic Acid—epilepsy syndrome	3.1e-05	0.000327	CcSEcCtD
Methadone—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.09e-05	0.000327	CcSEcCtD
Methadone—Oedema—Pregabalin—epilepsy syndrome	3.09e-05	0.000327	CcSEcCtD
Methadone—Ethopropazine—CHRM2—epilepsy syndrome	3.09e-05	0.0104	CrCbGaD
Methadone—Asthenia—Lamotrigine—epilepsy syndrome	3.09e-05	0.000327	CcSEcCtD
Methadone—Dizziness—Phenytoin—epilepsy syndrome	3.09e-05	0.000326	CcSEcCtD
Methadone—Rash—Zonisamide—epilepsy syndrome	3.07e-05	0.000325	CcSEcCtD
Methadone—Palpitations—Gabapentin—epilepsy syndrome	3.07e-05	0.000325	CcSEcCtD
Methadone—Dermatitis—Zonisamide—epilepsy syndrome	3.07e-05	0.000325	CcSEcCtD
Methadone—Dizziness—Oxcarbazepine—epilepsy syndrome	3.07e-05	0.000325	CcSEcCtD
Methadone—Nausea—Diazepam—epilepsy syndrome	3.06e-05	0.000323	CcSEcCtD
Methadone—Loss of consciousness—Gabapentin—epilepsy syndrome	3.06e-05	0.000323	CcSEcCtD
Methadone—Headache—Zonisamide—epilepsy syndrome	3.05e-05	0.000323	CcSEcCtD
Methadone—Diarrhoea—Carbamazepine—epilepsy syndrome	3.05e-05	0.000322	CcSEcCtD
Methadone—Pruritus—Lamotrigine—epilepsy syndrome	3.05e-05	0.000322	CcSEcCtD
Methadone—Shock—Pregabalin—epilepsy syndrome	3.04e-05	0.000322	CcSEcCtD
Methadone—Somnolence—Valproic Acid—epilepsy syndrome	3.04e-05	0.000322	CcSEcCtD
Methadone—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.03e-05	0.00032	CcSEcCtD
Methadone—Tachycardia—Pregabalin—epilepsy syndrome	3.02e-05	0.000319	CcSEcCtD
Methadone—Chills—Topiramate—epilepsy syndrome	3.01e-05	0.000319	CcSEcCtD
Methadone—Convulsion—Gabapentin—epilepsy syndrome	3.01e-05	0.000318	CcSEcCtD
Methadone—Orphenadrine—SCN1A—epilepsy syndrome	2.99e-05	0.0101	CrCbGaD
Methadone—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.99e-05	0.000316	CcSEcCtD
Methadone—Vomiting—Clonazepam—epilepsy syndrome	2.99e-05	0.000316	CcSEcCtD
Methadone—Decreased appetite—Valproic Acid—epilepsy syndrome	2.97e-05	0.000315	CcSEcCtD
Methadone—Vomiting—Phenytoin—epilepsy syndrome	2.97e-05	0.000314	CcSEcCtD
Methadone—Rash—Clonazepam—epilepsy syndrome	2.96e-05	0.000313	CcSEcCtD
Methadone—Dermatitis—Clonazepam—epilepsy syndrome	2.96e-05	0.000313	CcSEcCtD
Methadone—Nausea—Felbamate—epilepsy syndrome	2.96e-05	0.000313	CcSEcCtD
Methadone—Vomiting—Oxcarbazepine—epilepsy syndrome	2.95e-05	0.000312	CcSEcCtD
Methadone—Anxiety—Gabapentin—epilepsy syndrome	2.95e-05	0.000312	CcSEcCtD
Methadone—Anorexia—Pregabalin—epilepsy syndrome	2.95e-05	0.000312	CcSEcCtD
Methadone—Dizziness—Carbamazepine—epilepsy syndrome	2.95e-05	0.000312	CcSEcCtD
Methadone—Diarrhoea—Lamotrigine—epilepsy syndrome	2.95e-05	0.000312	CcSEcCtD
Methadone—Headache—Clonazepam—epilepsy syndrome	2.94e-05	0.000311	CcSEcCtD
Methadone—Rash—Phenytoin—epilepsy syndrome	2.94e-05	0.000311	CcSEcCtD
Methadone—Dermatitis—Phenytoin—epilepsy syndrome	2.94e-05	0.000311	CcSEcCtD
Methadone—Rash—Oxcarbazepine—epilepsy syndrome	2.93e-05	0.00031	CcSEcCtD
Methadone—Constipation—Valproic Acid—epilepsy syndrome	2.93e-05	0.000309	CcSEcCtD
Methadone—Pain—Valproic Acid—epilepsy syndrome	2.93e-05	0.000309	CcSEcCtD
Methadone—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.93e-05	0.000309	CcSEcCtD
Methadone—Headache—Phenytoin—epilepsy syndrome	2.92e-05	0.000309	CcSEcCtD
Methadone—Erythema—Topiramate—epilepsy syndrome	2.92e-05	0.000309	CcSEcCtD
Methadone—Headache—Oxcarbazepine—epilepsy syndrome	2.91e-05	0.000308	CcSEcCtD
Methadone—Nausea—Zonisamide—epilepsy syndrome	2.9e-05	0.000306	CcSEcCtD
Methadone—Dry mouth—Gabapentin—epilepsy syndrome	2.89e-05	0.000306	CcSEcCtD
Methadone—Hypotension—Pregabalin—epilepsy syndrome	2.89e-05	0.000306	CcSEcCtD
Methadone—Confusional state—Gabapentin—epilepsy syndrome	2.86e-05	0.000302	CcSEcCtD
Methadone—Dizziness—Lamotrigine—epilepsy syndrome	2.85e-05	0.000301	CcSEcCtD
Methadone—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.84e-05	0.0003	CcSEcCtD
Methadone—Oedema—Gabapentin—epilepsy syndrome	2.84e-05	0.0003	CcSEcCtD
Methadone—Vomiting—Carbamazepine—epilepsy syndrome	2.83e-05	0.0003	CcSEcCtD
Methadone—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.82e-05	0.000298	CcSEcCtD
Methadone—Muscle spasms—Topiramate—epilepsy syndrome	2.81e-05	0.000297	CcSEcCtD
Methadone—Rash—Carbamazepine—epilepsy syndrome	2.81e-05	0.000297	CcSEcCtD
Methadone—Dermatitis—Carbamazepine—epilepsy syndrome	2.81e-05	0.000297	CcSEcCtD
Methadone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.8e-05	0.000296	CcSEcCtD
Methadone—Insomnia—Pregabalin—epilepsy syndrome	2.8e-05	0.000296	CcSEcCtD
Methadone—Nausea—Clonazepam—epilepsy syndrome	2.79e-05	0.000295	CcSEcCtD
Methadone—Headache—Carbamazepine—epilepsy syndrome	2.79e-05	0.000295	CcSEcCtD
Methadone—Shock—Gabapentin—epilepsy syndrome	2.79e-05	0.000295	CcSEcCtD
Methadone—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.78e-05	0.000294	CcSEcCtD
Methadone—Nausea—Phenytoin—epilepsy syndrome	2.77e-05	0.000293	CcSEcCtD
Methadone—Tachycardia—Gabapentin—epilepsy syndrome	2.77e-05	0.000293	CcSEcCtD
Methadone—Nausea—Oxcarbazepine—epilepsy syndrome	2.76e-05	0.000292	CcSEcCtD
Methadone—Somnolence—Pregabalin—epilepsy syndrome	2.75e-05	0.000291	CcSEcCtD
Methadone—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.74e-05	0.00029	CcSEcCtD
Methadone—Tremor—Topiramate—epilepsy syndrome	2.74e-05	0.00029	CcSEcCtD
Methadone—Vomiting—Lamotrigine—epilepsy syndrome	2.74e-05	0.00029	CcSEcCtD
Methadone—Urticaria—Valproic Acid—epilepsy syndrome	2.72e-05	0.000287	CcSEcCtD
Methadone—Rash—Lamotrigine—epilepsy syndrome	2.72e-05	0.000287	CcSEcCtD
Methadone—Dermatitis—Lamotrigine—epilepsy syndrome	2.71e-05	0.000287	CcSEcCtD
Methadone—Dextropropoxyphene—OPRM1—epilepsy syndrome	2.71e-05	0.0091	CrCbGaD
Methadone—Abdominal pain—Valproic Acid—epilepsy syndrome	2.71e-05	0.000286	CcSEcCtD
Methadone—Body temperature increased—Valproic Acid—epilepsy syndrome	2.71e-05	0.000286	CcSEcCtD
Methadone—Anorexia—Gabapentin—epilepsy syndrome	2.7e-05	0.000286	CcSEcCtD
Methadone—Headache—Lamotrigine—epilepsy syndrome	2.7e-05	0.000285	CcSEcCtD
Methadone—Decreased appetite—Pregabalin—epilepsy syndrome	2.69e-05	0.000284	CcSEcCtD
Methadone—Agitation—Topiramate—epilepsy syndrome	2.69e-05	0.000284	CcSEcCtD
Methadone—Fentanyl—OPRM1—epilepsy syndrome	2.68e-05	0.009	CrCbGaD
Methadone—Hypotension—Gabapentin—epilepsy syndrome	2.65e-05	0.00028	CcSEcCtD
Methadone—Nausea—Carbamazepine—epilepsy syndrome	2.65e-05	0.00028	CcSEcCtD
Methadone—Pain—Pregabalin—epilepsy syndrome	2.65e-05	0.00028	CcSEcCtD
Methadone—Constipation—Pregabalin—epilepsy syndrome	2.65e-05	0.00028	CcSEcCtD
Methadone—Vertigo—Topiramate—epilepsy syndrome	2.63e-05	0.000278	CcSEcCtD
Methadone—Syncope—Topiramate—epilepsy syndrome	2.62e-05	0.000277	CcSEcCtD
Methadone—Palpitations—Topiramate—epilepsy syndrome	2.58e-05	0.000273	CcSEcCtD
Methadone—Loperamide—OPRM1—epilepsy syndrome	2.58e-05	0.00867	CrCbGaD
Methadone—Ethopropazine—BCHE—epilepsy syndrome	2.58e-05	0.00867	CrCbGaD
Methadone—Loss of consciousness—Topiramate—epilepsy syndrome	2.57e-05	0.000272	CcSEcCtD
Methadone—Insomnia—Gabapentin—epilepsy syndrome	2.57e-05	0.000271	CcSEcCtD
Methadone—Nausea—Lamotrigine—epilepsy syndrome	2.56e-05	0.00027	CcSEcCtD
Methadone—Feeling abnormal—Pregabalin—epilepsy syndrome	2.55e-05	0.00027	CcSEcCtD
Methadone—Convulsion—Topiramate—epilepsy syndrome	2.53e-05	0.000268	CcSEcCtD
Methadone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.53e-05	0.000268	CcSEcCtD
Methadone—Somnolence—Gabapentin—epilepsy syndrome	2.52e-05	0.000267	CcSEcCtD
Methadone—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.52e-05	0.000267	CcSEcCtD
Methadone—Anxiety—Topiramate—epilepsy syndrome	2.48e-05	0.000262	CcSEcCtD
Methadone—Decreased appetite—Gabapentin—epilepsy syndrome	2.47e-05	0.000261	CcSEcCtD
Methadone—Propiomazine—CHRM3—epilepsy syndrome	2.46e-05	0.00827	CrCbGaD
Methadone—Urticaria—Pregabalin—epilepsy syndrome	2.46e-05	0.00026	CcSEcCtD
Methadone—Asthenia—Valproic Acid—epilepsy syndrome	2.46e-05	0.00026	CcSEcCtD
Methadone—Abdominal pain—Pregabalin—epilepsy syndrome	2.45e-05	0.000259	CcSEcCtD
Methadone—Body temperature increased—Pregabalin—epilepsy syndrome	2.45e-05	0.000259	CcSEcCtD
Methadone—Dry mouth—Topiramate—epilepsy syndrome	2.43e-05	0.000257	CcSEcCtD
Methadone—Constipation—Gabapentin—epilepsy syndrome	2.43e-05	0.000257	CcSEcCtD
Methadone—Pain—Gabapentin—epilepsy syndrome	2.43e-05	0.000257	CcSEcCtD
Methadone—Pruritus—Valproic Acid—epilepsy syndrome	2.42e-05	0.000256	CcSEcCtD
Methadone—Confusional state—Topiramate—epilepsy syndrome	2.41e-05	0.000254	CcSEcCtD
Methadone—Oedema—Topiramate—epilepsy syndrome	2.39e-05	0.000252	CcSEcCtD
Methadone—Clotrimazole—ABCC2—epilepsy syndrome	2.35e-05	0.00791	CrCbGaD
Methadone—Shock—Topiramate—epilepsy syndrome	2.35e-05	0.000248	CcSEcCtD
Methadone—Diarrhoea—Valproic Acid—epilepsy syndrome	2.34e-05	0.000248	CcSEcCtD
Methadone—Feeling abnormal—Gabapentin—epilepsy syndrome	2.34e-05	0.000247	CcSEcCtD
Methadone—Thrombocytopenia—Topiramate—epilepsy syndrome	2.34e-05	0.000247	CcSEcCtD
Methadone—Tachycardia—Topiramate—epilepsy syndrome	2.33e-05	0.000246	CcSEcCtD
Methadone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.32e-05	0.000245	CcSEcCtD
Methadone—Hyperhidrosis—Topiramate—epilepsy syndrome	2.31e-05	0.000244	CcSEcCtD
Methadone—Propiomazine—CHRM1—epilepsy syndrome	2.3e-05	0.00772	CrCbGaD
Methadone—Hypersensitivity—Pregabalin—epilepsy syndrome	2.28e-05	0.000241	CcSEcCtD
Methadone—Anorexia—Topiramate—epilepsy syndrome	2.28e-05	0.000241	CcSEcCtD
Methadone—Dizziness—Valproic Acid—epilepsy syndrome	2.26e-05	0.000239	CcSEcCtD
Methadone—Urticaria—Gabapentin—epilepsy syndrome	2.25e-05	0.000238	CcSEcCtD
Methadone—Abdominal pain—Gabapentin—epilepsy syndrome	2.24e-05	0.000237	CcSEcCtD
Methadone—Body temperature increased—Gabapentin—epilepsy syndrome	2.24e-05	0.000237	CcSEcCtD
Methadone—Hypotension—Topiramate—epilepsy syndrome	2.23e-05	0.000236	CcSEcCtD
Methadone—Trospium—CYP2D6—epilepsy syndrome	2.22e-05	0.00747	CrCbGaD
Methadone—Asthenia—Pregabalin—epilepsy syndrome	2.22e-05	0.000235	CcSEcCtD
Methadone—Pruritus—Pregabalin—epilepsy syndrome	2.19e-05	0.000231	CcSEcCtD
Methadone—Vomiting—Valproic Acid—epilepsy syndrome	2.18e-05	0.00023	CcSEcCtD
Methadone—Insomnia—Topiramate—epilepsy syndrome	2.16e-05	0.000228	CcSEcCtD
Methadone—Rash—Valproic Acid—epilepsy syndrome	2.16e-05	0.000228	CcSEcCtD
Methadone—Dermatitis—Valproic Acid—epilepsy syndrome	2.16e-05	0.000228	CcSEcCtD
Methadone—Headache—Valproic Acid—epilepsy syndrome	2.14e-05	0.000227	CcSEcCtD
Methadone—Somnolence—Topiramate—epilepsy syndrome	2.12e-05	0.000224	CcSEcCtD
Methadone—Diarrhoea—Pregabalin—epilepsy syndrome	2.12e-05	0.000224	CcSEcCtD
Methadone—Hypersensitivity—Gabapentin—epilepsy syndrome	2.09e-05	0.000221	CcSEcCtD
Methadone—Decreased appetite—Topiramate—epilepsy syndrome	2.07e-05	0.000219	CcSEcCtD
Methadone—Promethazine—CHRM3—epilepsy syndrome	2.07e-05	0.00697	CrCbGaD
Methadone—Dizziness—Pregabalin—epilepsy syndrome	2.05e-05	0.000216	CcSEcCtD
Methadone—Pain—Topiramate—epilepsy syndrome	2.04e-05	0.000216	CcSEcCtD
Methadone—Constipation—Topiramate—epilepsy syndrome	2.04e-05	0.000216	CcSEcCtD
Methadone—Asthenia—Gabapentin—epilepsy syndrome	2.04e-05	0.000215	CcSEcCtD
Methadone—Nausea—Valproic Acid—epilepsy syndrome	2.03e-05	0.000215	CcSEcCtD
Methadone—Pruritus—Gabapentin—epilepsy syndrome	2.01e-05	0.000212	CcSEcCtD
Methadone—Vomiting—Pregabalin—epilepsy syndrome	1.97e-05	0.000208	CcSEcCtD
Methadone—Feeling abnormal—Topiramate—epilepsy syndrome	1.97e-05	0.000208	CcSEcCtD
Methadone—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.95e-05	0.000206	CcSEcCtD
Methadone—Rash—Pregabalin—epilepsy syndrome	1.95e-05	0.000206	CcSEcCtD
Methadone—Dermatitis—Pregabalin—epilepsy syndrome	1.95e-05	0.000206	CcSEcCtD
Methadone—Diarrhoea—Gabapentin—epilepsy syndrome	1.94e-05	0.000205	CcSEcCtD
Methadone—Headache—Pregabalin—epilepsy syndrome	1.94e-05	0.000205	CcSEcCtD
Methadone—Promethazine—CHRM1—epilepsy syndrome	1.93e-05	0.0065	CrCbGaD
Methadone—Urticaria—Topiramate—epilepsy syndrome	1.9e-05	0.0002	CcSEcCtD
Methadone—Abdominal pain—Topiramate—epilepsy syndrome	1.89e-05	0.0002	CcSEcCtD
Methadone—Body temperature increased—Topiramate—epilepsy syndrome	1.89e-05	0.0002	CcSEcCtD
Methadone—Dizziness—Gabapentin—epilepsy syndrome	1.88e-05	0.000198	CcSEcCtD
Methadone—Propiomazine—CHRM2—epilepsy syndrome	1.87e-05	0.0063	CrCbGaD
Methadone—Tripelennamine—CYP2D6—epilepsy syndrome	1.87e-05	0.00628	CrCbGaD
Methadone—Nausea—Pregabalin—epilepsy syndrome	1.84e-05	0.000194	CcSEcCtD
Methadone—Vomiting—Gabapentin—epilepsy syndrome	1.8e-05	0.000191	CcSEcCtD
Methadone—Rash—Gabapentin—epilepsy syndrome	1.79e-05	0.000189	CcSEcCtD
Methadone—Dermatitis—Gabapentin—epilepsy syndrome	1.79e-05	0.000189	CcSEcCtD
Methadone—Headache—Gabapentin—epilepsy syndrome	1.78e-05	0.000188	CcSEcCtD
Methadone—Hypersensitivity—Topiramate—epilepsy syndrome	1.76e-05	0.000186	CcSEcCtD
Methadone—Oxaprozin—PTGS2—epilepsy syndrome	1.72e-05	0.00578	CrCbGaD
Methadone—Benzphetamine—ADRA2A—epilepsy syndrome	1.71e-05	0.00576	CrCbGaD
Methadone—Asthenia—Topiramate—epilepsy syndrome	1.71e-05	0.000181	CcSEcCtD
Methadone—Pruritus—Topiramate—epilepsy syndrome	1.69e-05	0.000179	CcSEcCtD
Methadone—Nausea—Gabapentin—epilepsy syndrome	1.69e-05	0.000178	CcSEcCtD
Methadone—Phenoxybenzamine—ADRA2A—epilepsy syndrome	1.64e-05	0.00551	CrCbGaD
Methadone—Clotrimazole—CYP2C19—epilepsy syndrome	1.64e-05	0.0055	CrCbGaD
Methadone—Diarrhoea—Topiramate—epilepsy syndrome	1.63e-05	0.000173	CcSEcCtD
Methadone—Darifenacin—CYP2D6—epilepsy syndrome	1.61e-05	0.00542	CrCbGaD
Methadone—Diphenhydramine—CHRM2—epilepsy syndrome	1.61e-05	0.00541	CrCbGaD
Methadone—Promethazine—CHRM2—epilepsy syndrome	1.58e-05	0.00531	CrCbGaD
Methadone—Dizziness—Topiramate—epilepsy syndrome	1.58e-05	0.000167	CcSEcCtD
Methadone—Fexofenadine—CYP2D6—epilepsy syndrome	1.57e-05	0.00528	CrCbGaD
Methadone—Orphenadrine—CHRM2—epilepsy syndrome	1.52e-05	0.00512	CrCbGaD
Methadone—Vomiting—Topiramate—epilepsy syndrome	1.52e-05	0.00016	CcSEcCtD
Methadone—Rash—Topiramate—epilepsy syndrome	1.5e-05	0.000159	CcSEcCtD
Methadone—Dermatitis—Topiramate—epilepsy syndrome	1.5e-05	0.000159	CcSEcCtD
Methadone—Headache—Topiramate—epilepsy syndrome	1.5e-05	0.000158	CcSEcCtD
Methadone—Modafinil—CYP2C19—epilepsy syndrome	1.43e-05	0.00481	CrCbGaD
Methadone—Nausea—Topiramate—epilepsy syndrome	1.42e-05	0.00015	CcSEcCtD
Methadone—Trimipramine—ADRA2A—epilepsy syndrome	1.4e-05	0.0047	CrCbGaD
Methadone—Tamoxifen—ABCC2—epilepsy syndrome	1.39e-05	0.00468	CrCbGaD
Methadone—Atomoxetine—SLC6A4—epilepsy syndrome	1.3e-05	0.00436	CrCbGaD
Methadone—Tamoxifen—ABCG2—epilepsy syndrome	1.23e-05	0.00414	CrCbGaD
Methadone—Atomoxetine—CYP2C19—epilepsy syndrome	1.23e-05	0.00414	CrCbGaD
Methadone—Clotrimazole—CYP2D6—epilepsy syndrome	1.21e-05	0.00408	CrCbGaD
Methadone—Phenylbutazone—PTGS2—epilepsy syndrome	1.14e-05	0.00382	CrCbGaD
Methadone—Fexofenadine—ABCB1—epilepsy syndrome	1.12e-05	0.00377	CrCbGaD
Methadone—Trimipramine—SLC6A4—epilepsy syndrome	1.07e-05	0.00359	CrCbGaD
Methadone—Dextropropoxyphene—CYP2D6—epilepsy syndrome	1.05e-05	0.00352	CrCbGaD
Methadone—Trimipramine—CYP2C19—epilepsy syndrome	1.01e-05	0.0034	CrCbGaD
Methadone—Loperamide—CYP2D6—epilepsy syndrome	9.99e-06	0.00336	CrCbGaD
Methadone—Atomoxetine—HTR2A—epilepsy syndrome	9.97e-06	0.00335	CrCbGaD
Methadone—Diphenhydramine—CYP2C19—epilepsy syndrome	9.94e-06	0.00334	CrCbGaD
Methadone—Tamoxifen—CYP2C19—epilepsy syndrome	9.67e-06	0.00325	CrCbGaD
Methadone—Propiomazine—HTR2A—epilepsy syndrome	9.38e-06	0.00315	CrCbGaD
Methadone—Atomoxetine—CYP2D6—epilepsy syndrome	9.12e-06	0.00307	CrCbGaD
Methadone—Clotrimazole—ABCB1—epilepsy syndrome	8.66e-06	0.00291	CrCbGaD
Methadone—Trimipramine—HTR2A—epilepsy syndrome	8.2e-06	0.00276	CrCbGaD
Methadone—Promethazine—HTR2A—epilepsy syndrome	7.9e-06	0.00266	CrCbGaD
Methadone—Trimipramine—CYP2D6—epilepsy syndrome	7.5e-06	0.00252	CrCbGaD
Methadone—Fentanyl—ABCB1—epilepsy syndrome	7.4e-06	0.00249	CrCbGaD
Methadone—Diphenhydramine—CYP2D6—epilepsy syndrome	7.37e-06	0.00248	CrCbGaD
Methadone—Promethazine—CYP2D6—epilepsy syndrome	7.22e-06	0.00243	CrCbGaD
Methadone—Tamoxifen—CYP2D6—epilepsy syndrome	7.17e-06	0.00241	CrCbGaD
Methadone—Loperamide—ABCB1—epilepsy syndrome	7.13e-06	0.0024	CrCbGaD
Methadone—Trimipramine—ABCB1—epilepsy syndrome	5.36e-06	0.0018	CrCbGaD
Methadone—Promethazine—ABCB1—epilepsy syndrome	5.16e-06	0.00173	CrCbGaD
Methadone—Tamoxifen—ABCB1—epilepsy syndrome	5.12e-06	0.00172	CrCbGaD
Methadone—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	1.92e-06	4.31e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—APOE—epilepsy syndrome	1.91e-06	4.3e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.91e-06	4.3e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	1.91e-06	4.29e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.91e-06	4.29e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	1.9e-06	4.28e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.9e-06	4.27e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.9e-06	4.27e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.9e-06	4.27e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.89e-06	4.25e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	1.88e-06	4.23e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—TH—epilepsy syndrome	1.88e-06	4.22e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	1.87e-06	4.21e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	1.87e-06	4.21e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.86e-06	4.18e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.85e-06	4.15e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	1.83e-06	4.11e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.83e-06	4.11e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	1.82e-06	4.1e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	1.82e-06	4.1e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.82e-06	4.08e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.81e-06	4.07e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.81e-06	4.07e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.8e-06	4.05e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	1.8e-06	4.05e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	1.79e-06	4.03e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.79e-06	4.02e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.78e-06	4e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.78e-06	4e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	1.78e-06	3.99e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.77e-06	3.98e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.77e-06	3.98e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.76e-06	3.95e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.74e-06	3.9e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	1.74e-06	3.9e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.74e-06	3.9e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.73e-06	3.88e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.71e-06	3.85e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTGS2—epilepsy syndrome	1.71e-06	3.85e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.7e-06	3.83e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.7e-06	3.81e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.7e-06	3.81e-05	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.68e-06	3.77e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.67e-06	3.76e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.67e-06	3.75e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.66e-06	3.73e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.66e-06	3.73e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.66e-06	3.72e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	1.66e-06	3.72e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.65e-06	3.72e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	1.65e-06	3.71e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.65e-06	3.7e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	1.65e-06	3.7e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.64e-06	3.69e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—POMC—epilepsy syndrome	1.64e-06	3.69e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	1.64e-06	3.69e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.63e-06	3.67e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.63e-06	3.67e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.63e-06	3.66e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.63e-06	3.66e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—TH—epilepsy syndrome	1.63e-06	3.65e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.62e-06	3.65e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	1.62e-06	3.63e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	1.61e-06	3.61e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.6e-06	3.6e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.6e-06	3.59e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.59e-06	3.57e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	1.58e-06	3.55e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.58e-06	3.55e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.57e-06	3.52e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.56e-06	3.51e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.55e-06	3.48e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.55e-06	3.47e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.54e-06	3.47e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.54e-06	3.45e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	1.54e-06	3.45e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.52e-06	3.42e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.52e-06	3.41e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.52e-06	3.41e-05	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.52e-06	3.4e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.51e-06	3.4e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	1.51e-06	3.39e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.51e-06	3.38e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.5e-06	3.38e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ALB—epilepsy syndrome	1.5e-06	3.37e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.49e-06	3.34e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.48e-06	3.33e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.47e-06	3.31e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.46e-06	3.27e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	1.45e-06	3.26e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.45e-06	3.26e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—TH—epilepsy syndrome	1.45e-06	3.26e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.44e-06	3.23e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.43e-06	3.21e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.43e-06	3.21e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.43e-06	3.21e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.43e-06	3.2e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.42e-06	3.19e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.42e-06	3.19e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—TH—epilepsy syndrome	1.42e-06	3.18e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.41e-06	3.18e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.41e-06	3.17e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.41e-06	3.16e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.41e-06	3.16e-05	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.4e-06	3.14e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.4e-06	3.14e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.4e-06	3.13e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	1.39e-06	3.12e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	1.39e-06	3.11e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.37e-06	3.09e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.37e-06	3.09e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.36e-06	3.05e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.36e-06	3.05e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.35e-06	3.04e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	1.35e-06	3.03e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	1.35e-06	3.02e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.34e-06	3.02e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.34e-06	3.01e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.34e-06	3.01e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—TH—epilepsy syndrome	1.33e-06	3e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.33e-06	2.98e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—TH—epilepsy syndrome	1.32e-06	2.97e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	1.32e-06	2.97e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	1.31e-06	2.94e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	1.31e-06	2.94e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.3e-06	2.93e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.3e-06	2.92e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.3e-06	2.92e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.27e-06	2.86e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	1.27e-06	2.85e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.27e-06	2.85e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.25e-06	2.82e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.23e-06	2.76e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.23e-06	2.76e-05	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.23e-06	2.76e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.23e-06	2.75e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	1.22e-06	2.73e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.21e-06	2.72e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.21e-06	2.72e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	1.21e-06	2.71e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.21e-06	2.71e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.2e-06	2.7e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.2e-06	2.7e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.19e-06	2.68e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.18e-06	2.65e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	1.18e-06	2.65e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	1.18e-06	2.64e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CAT—epilepsy syndrome	1.17e-06	2.62e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.16e-06	2.61e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	1.15e-06	2.58e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.15e-06	2.58e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	1.14e-06	2.56e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.14e-06	2.56e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.13e-06	2.55e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—TH—epilepsy syndrome	1.13e-06	2.54e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.12e-06	2.52e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.12e-06	2.51e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	1.11e-06	2.5e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.11e-06	2.5e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.11e-06	2.5e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.1e-06	2.48e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.1e-06	2.47e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.09e-06	2.45e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.09e-06	2.45e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.08e-06	2.44e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.08e-06	2.43e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.07e-06	2.4e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.06e-06	2.38e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.06e-06	2.38e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	1.06e-06	2.38e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.06e-06	2.37e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.05e-06	2.37e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.04e-06	2.34e-05	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.04e-06	2.33e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.03e-06	2.32e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	1.03e-06	2.32e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.03e-06	2.31e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	9.98e-07	2.24e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	9.94e-07	2.23e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GPX1—epilepsy syndrome	9.85e-07	2.21e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	9.79e-07	2.2e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	9.71e-07	2.18e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALB—epilepsy syndrome	9.62e-07	2.16e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AGT—epilepsy syndrome	9.47e-07	2.13e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	9.44e-07	2.12e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	9.42e-07	2.11e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALB—epilepsy syndrome	9.4e-07	2.11e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	9.32e-07	2.09e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CAT—epilepsy syndrome	9.31e-07	2.09e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOE—epilepsy syndrome	9.28e-07	2.09e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	9.28e-07	2.08e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AGT—epilepsy syndrome	9.25e-07	2.08e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOE—epilepsy syndrome	9.06e-07	2.04e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	9.06e-07	2.03e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	8.95e-07	2.01e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—POMC—epilepsy syndrome	8.93e-07	2.01e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	8.85e-07	1.99e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	8.76e-07	1.97e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TH—epilepsy syndrome	8.72e-07	1.96e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	8.72e-07	1.96e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AGT—epilepsy syndrome	8.71e-07	1.96e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AGT—epilepsy syndrome	8.64e-07	1.94e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—AKT1—epilepsy syndrome	8.61e-07	1.93e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOE—epilepsy syndrome	8.54e-07	1.92e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOE—epilepsy syndrome	8.46e-07	1.9e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GPX1—epilepsy syndrome	8.42e-07	1.89e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	8.42e-07	1.89e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	8.23e-07	1.85e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALB—epilepsy syndrome	8.15e-07	1.83e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—POMC—epilepsy syndrome	7.97e-07	1.79e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—POMC—epilepsy syndrome	7.78e-07	1.75e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	7.5e-07	1.69e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AGT—epilepsy syndrome	7.38e-07	1.66e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—POMC—epilepsy syndrome	7.34e-07	1.65e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	7.28e-07	1.64e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—POMC—epilepsy syndrome	7.27e-07	1.63e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALB—epilepsy syndrome	7.27e-07	1.63e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOE—epilepsy syndrome	7.23e-07	1.62e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CAT—epilepsy syndrome	7.18e-07	1.61e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	7.13e-07	1.6e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALB—epilepsy syndrome	7.1e-07	1.59e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	6.99e-07	1.57e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALB—epilepsy syndrome	6.69e-07	1.5e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALB—epilepsy syndrome	6.63e-07	1.49e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—AKT1—epilepsy syndrome	6.59e-07	1.48e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	6.58e-07	1.48e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	6.5e-07	1.46e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	6.36e-07	1.43e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—POMC—epilepsy syndrome	6.21e-07	1.4e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—epilepsy syndrome	6.21e-07	1.39e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	5.85e-07	1.31e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	5.8e-07	1.3e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—AKT1—epilepsy syndrome	5.72e-07	1.29e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.7e-07	1.28e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALB—epilepsy syndrome	5.67e-07	1.27e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.58e-07	1.25e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	5.56e-07	1.25e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	4.96e-07	1.11e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.8e-07	1.08e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.37e-07	9.82e-06	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AKT1—epilepsy syndrome	4.23e-07	9.5e-06	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AKT1—epilepsy syndrome	4.14e-07	9.29e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.83e-07	8.59e-06	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKT1—epilepsy syndrome	3.58e-07	8.05e-06	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.2e-07	7.18e-06	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKT1—epilepsy syndrome	3.12e-07	7.01e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.94e-07	6.61e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.92e-07	6.55e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.49e-07	5.6e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.92e-07	4.32e-06	CbGpPWpGaD
